Recent articles from Wiley Online Library (free access):
* Cárdenas‐Conejo, Y. [et al.]. (13 March 2020). An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human‐pathogenic coronavirus (SARS‐CoV2). Journal of Medical Virology. https://doi.org/10.1002/jmv.25758
* Lung, J. [et al.]. (13 March 2020). The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase. Journal of medical Virology. https://doi.org/10.1002/jmv.25761
* Wang, C. [et al.]. (13 March 2020). The establishment of reference sequence for SARS‐CoV‐2 and variation analysis. Journal of medical Virology. https://doi.org/10.1002/jmv.25762
* Zhu, W. [et al.]. (13 March 2020). Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei, China. Journal of medical Virology. https://doi.org/10.1002/jmv.25763
* Long, Y. [et al.]. (13 March 2020). Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta‐analysis. Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.12381
* Zhuang, Q. [et al.]. (12 March 2020). Surveillance and Taxonomic Analysis of the Coronavirus Dominant in Pigeons in China. Transboundary and Emerging Diseases. https://doi.org/10.1111/tbed.13541
* Chen, Q. [et al.]. (12 March 2020).A report of clinical diagnosis and treatment of 9 cases of coronavirus disease 2019. Journal of Medical Virology. https://doi.org/10.1002/jmv.25755
* Li, L. [et al.]. (12 March 2020). 2019 novel coronavirus patients’ clinical characteristics, discharge rate and fatality rate of meta‐analysis. Journal of Medical Virology. https://doi.org/10.1002/jmv.25757
* Garnier-Crussard, A. [et al.]. (12 March 2020). Novel Coronavirus (COVID‐19) Epidemic: What Are the Risks for Older Patients? Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.16407
* Ton, A.T. [et al.]. (11 March 2020). Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds. Molecular Informatics. https://doi.org/10.1002/minf.202000028
* Zhu, F. [et al.]. (11 March 2020). Co‐infection of SARS‐CoV‐2 and HIV in a patient in Wuhan city, China. Journal of Medical Virology.
https://doi.org/10.1002/jmv.25732
* Conway, M.J. (11 March 2020). Identification of Coronavirus Sequences in Carp cDNA from Wuhan, China. Journal of Medical Virology.
https://doi.org/10.1002/jmv.25751
* Kandeel, M. [et al.]. (11 March 2020). From SARS and MERS CoVs to SARS‐CoV‐2: moving toward more biased codon usage in viral structural and non‐structural genes. Journal of Medical Virology.
https://doi.org/10.1002/jmv.25754
* Poon, L.C. [et al.]. (11 March 2020). ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.22013
* Conforti, C. [et al.]. (11 March 2020). COVID‐19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action. Dermatologic Terapy. https://doi.org/10.1111/dth.13298
* Thomson, G.A. (11 March 2020). Where are we now with COVID‐19? The International Journal of Clinical Practice. https://doi.org/10.1111/ijcp.13497
* Chenoweth, A.M. [et al.]. (11 March 2020). Harnessing the immune system via FcγR function in immune therapy: A pathway to next‐gen mAbs. Immunology & Cell Biology. https://doi.org/10.1111/imcb.12326
* Joob, B. & Wiwanitkit, V. (10 March 2020). Frequency of arrhythmia in novel coronavirus 2019 infection. Journal of Arrhythmia. https://doi.org/10.1002/joa3.12330
CLICK HERE to view ALL Novel Coronavirus Outbreak articles, covering the period December 2019 to present, in the Wiley Online Library.
Showing posts with label 2019 Novel Coronavirus. Show all posts
Showing posts with label 2019 Novel Coronavirus. Show all posts
Monday, March 16, 2020
Sunday, March 1, 2020
Medical Xpress article (27 February 2020) - Existing drugs may offer a first-line treatment for coronavirus outbreak
Title:
Existing drugs may offer a first-line treatment for coronavirus outbreak
Authors:
Petter I. Andersen, Aleksandr Ianevski, Hilde Lysvand, Astra Vitkauskiene, Valentyn Oksenych, Magnar Bjøras, Kaidi Telling, Irja Lutsar, Uga Dampis, Yasuhiko Irie, Tanel Tenson, Anu Kantele & Denis E. Kainov
Published:
Medical Xpress, 27 February 2020
From the article:
"The number of people infected with the new coronavirus continues to skyrocket, with more than 80,000 cases worldwide as of the end of February. But there's no vaccine or cure in sight, meaning that doctors can do little more than offer supportive treatment to the very sick and hope their bodies can survive the infection.
Now, however, a coalition of European researchers says that already approved drugs might hold the key to treating the new virus. Their findings have been published as a pre-proof in the International Journal of Infectious Diseases."
To read this article:
https://medicalxpress.com/news/2020-02-drugs-first-line-treatment-coronavirus-outbreak.html
For more information, see scholarly article:
Petter I. Andersen et al, Discovery and development of safe-in-man broad-spectrum antiviral agents, International Journal of Infectious Diseases (2020). https://doi.org/10.1016/j.ijid.2020.02.018
Existing drugs may offer a first-line treatment for coronavirus outbreak
Authors:
Petter I. Andersen, Aleksandr Ianevski, Hilde Lysvand, Astra Vitkauskiene, Valentyn Oksenych, Magnar Bjøras, Kaidi Telling, Irja Lutsar, Uga Dampis, Yasuhiko Irie, Tanel Tenson, Anu Kantele & Denis E. Kainov
Published:
Medical Xpress, 27 February 2020
From the article:
"The number of people infected with the new coronavirus continues to skyrocket, with more than 80,000 cases worldwide as of the end of February. But there's no vaccine or cure in sight, meaning that doctors can do little more than offer supportive treatment to the very sick and hope their bodies can survive the infection.
Now, however, a coalition of European researchers says that already approved drugs might hold the key to treating the new virus. Their findings have been published as a pre-proof in the International Journal of Infectious Diseases."
To read this article:
https://medicalxpress.com/news/2020-02-drugs-first-line-treatment-coronavirus-outbreak.html
For more information, see scholarly article:
Petter I. Andersen et al, Discovery and development of safe-in-man broad-spectrum antiviral agents, International Journal of Infectious Diseases (2020). https://doi.org/10.1016/j.ijid.2020.02.018
Friday, February 28, 2020
Canceling of Conferences - Coronavirus jolts tech firms: Facebook cancels F8 conference; Microsoft, Apple warn: The global tech industry is being rattled by the virus.
Title:
Coronavirus jolts tech firms: Facebook cancels F8 conference; Microsoft, Apple warn
Author:
Andrew Morse & Kent German
Published:
CNET, 28 February 2020
From the article:
"The novel coronavirus continues to wreak havoc in the global technology industry with three big conferences -- Facebook's F8, the Geneva Motor Show and Mobile World Congress -- being called of because the outbreak."
To read the article:
https://www.cnet.com/news/coronavirus-jolts-tech-firms-facebook-cancels-f8-conference-microsoft-apple-warn/
Coronavirus jolts tech firms: Facebook cancels F8 conference; Microsoft, Apple warn
Author:
Andrew Morse & Kent German
Published:
CNET, 28 February 2020
From the article:
"The novel coronavirus continues to wreak havoc in the global technology industry with three big conferences -- Facebook's F8, the Geneva Motor Show and Mobile World Congress -- being called of because the outbreak."
To read the article:
https://www.cnet.com/news/coronavirus-jolts-tech-firms-facebook-cancels-f8-conference-microsoft-apple-warn/
Tuesday, February 25, 2020
EAIE Blog Post: Supporting students affected by coronavirus
Title:
Supporting students affected by coronavirus
Authors:
Louise Staunton & Frank Haber
Published:
EAIE Blog, 20 February 2020
From the blog post:
"In recent months, the emergence of the Coronavirus (also known as COVID-19) has sent ripples across the world of higher education. This outbreak has not only highlighted the vulnerability of international students to such risks, but also the threat to international mobility posed by a virus which knows no borders."
To read this blog post:
https://www.eaie.org/blog/supporting-students-coronavirus.html
NOTE:
EAIE is currently conducting a survey to learn more about the effect of the coronavirus outbresk on international higher education.
Supporting students affected by coronavirus
Authors:
Louise Staunton & Frank Haber
Published:
EAIE Blog, 20 February 2020
From the blog post:
"In recent months, the emergence of the Coronavirus (also known as COVID-19) has sent ripples across the world of higher education. This outbreak has not only highlighted the vulnerability of international students to such risks, but also the threat to international mobility posed by a virus which knows no borders."
To read this blog post:
https://www.eaie.org/blog/supporting-students-coronavirus.html
NOTE:
EAIE is currently conducting a survey to learn more about the effect of the coronavirus outbresk on international higher education.
Sunday, February 23, 2020
Short Article - Health officials worry as untraceable virus clusters emerge (Covid-19)
Title:
Health officials worry as untraceable virus clusters emerge
Authors:
Aniruddha Ghosal & Lauran Neergaard
Published:
Medical Xpress, 22 February 2020
From the article:
"In South Korea, Singapore and Iran, clusters of infections are leading to a jump in cases of the new viral illness outside China. But it's not the numbers that are worrying experts: It's that increasingly they can't trace where the clusters started."
To read this article:
https://medicalxpress.com/news/2020-02-health-untraceable-virus-clusters-emerge.html
Health officials worry as untraceable virus clusters emerge
Authors:
Aniruddha Ghosal & Lauran Neergaard
Published:
Medical Xpress, 22 February 2020
From the article:
"In South Korea, Singapore and Iran, clusters of infections are leading to a jump in cases of the new viral illness outside China. But it's not the numbers that are worrying experts: It's that increasingly they can't trace where the clusters started."
To read this article:
https://medicalxpress.com/news/2020-02-health-untraceable-virus-clusters-emerge.html
Tuesday, February 18, 2020
Some of the Latest Information Resources on Covid-19 (Mostly articles published on 17 & 18 February 2020)
CURRENT SITUATION
The Worldometer for the Coronavirus can be accessed
here:
https://www.worldometers.info/coronavirus/
This Worldometer also provides confirmed cases and deaths by country and territory.
Statistical information at time of this blog post publication:
* Coronavirus cases: 73,428
* Number in serious/critical condition: 11,795
* Deaths: 1,874
* Recovered: 13,105
SHORT ARTICLES/NEWS UPDATES
Short article/news updates in order of original publish date
Before 17 February 2020
Title: Fake news makes disease outbreaks worse, research shows
Published: Phys.org, 14 February 2020
From the article:
* The worry that fake news might be used to distort political processes or manipulate financial markets is well established. But less studied is the possibility that misinformation spread could harm human health, especially during the outbreak of an infectious disease.
Click here to read this article
17 February 2020
Title: Amid Covid-19 panic, thieves make off with hundreds of rolls of toilet paper in Hong Kong
Published: MarketWatch 17 February 2020
From the article:
* The territory has one of the highest incidences of confirmed cases of the deadly viral illnesses — 56 according to the World Health Organization — outside of the disease’s epicenter in mainland China. That has led to reports of panic buying of items such as masks, hand sanitizers and other goods, alongside viral photos of empty supermarket shelves.
Click here to read this article
Title: Antimalarial drug confirmed effective on COVID-19
Published: XinhuaNet, 17 February 2020
From the article:
* Chinese experts, based on the result of clinical trials, have confirmed that Chloroquine Phosphate, an antimalarial drug, has a certain curative effect on the novel coronavirus disease (COVID-19), a Chinese official said here Monday.
Click here to read this article
Title: Apple to miss revenue forecast as iPhone supply hit by coronavirus
Published: TechXplore, 17 February 2020
From the article:
* Apple announced Monday it would miss its March quarter revenue forecast and global iPhone supplies would fall because of the deadly coronavirus epidemic, triggering a fall in Asian stock markets.
Click here to read this article
Title: Covid-19 Resources
Published: Gov.sg, 17 February 2020
From the article:
* A collection of useful posters and videos on Covid-19 (Coronavirus Disease 2019).
Click here to read this article
Title: eSwatini (Swaziland): Suspected Coronavirus case tests negative
Published: APA News, 17 February 2020
From the article:
* An eSwatini woman suspected of having contracted Coronavirus (Covid-19) has tested negative of the dreaded disease, health officials announced on Monday.
Click here to read this article
Title: Misinformation about COVID-19 hurting many Vancouver Chinese businesses
Published: Citi News 1130, 17 February 2020
From the article:
* The operator of a Vancouver Chinese restaurant fears the business won’t last three more months due to misinformation being spread about the COVID-19 outbreak.
Click here to read this article
Title: Xi had early knowledge of coronavirus severity, speech shows
Published: News24, 17 February 2020
From the article:
* In the early days of the epidemic, which has been one of the biggest political challenges of Xi's tenure, the president seemed to play a muted role, partly fuelling criticism of the government's approach to the outbreak.
* But during a speech Xi delivered on February 3, which was published by state media on Saturday, he said he gave instructions on fighting the virus as early as January 7.
* In the address, Xi said he ordered the shutdowns at the epicentre: "On January 22, in light of the epidemic's rapid spread and the challenges of prevention and control, I made a clear request that Hubei province implement comprehensive and stringent controls over the outflow of people."
Click here to read this article
18 February 2020
Title: China approves first anti-viral drug against coronavirus Covid-19
Published: Pharmaceutical-technology.com, 18 February 2020
From the article:
* Anti-viral drug Favilavir has secured approval from the National Medical Products Administration of China to treat coronavirus Covid-19, according to media reports..
Click here to read this article
Title: Most coronavirus infections are mild, says Chinese study
Published: Medical Xpress, 18 February 2020
From the article:
* Most people infected by the new coronavirus in China have mild symptoms, with older patients and those with underlying conditions most at risk from the disease, according to a study by Chinese researchers.
Click here to read this article
Title: Wuhan director & family dies of Covid-19 virus after delays in treatment due to lack of hospital beds
Published: Mothership, 18 February 2020
From the article:
* A Chinese film director from Hubei province, 55-year-old Chang Kai, died from Covid-19.
* Within 12 days, not only did Covid-19 take Chang’s life, but it also killed his sister and parents.
Click here to read this article
The Worldometer for the Coronavirus can be accessed
here:
https://www.worldometers.info/coronavirus/
This Worldometer also provides confirmed cases and deaths by country and territory.
Statistical information at time of this blog post publication:
* Coronavirus cases: 73,428
* Number in serious/critical condition: 11,795
* Deaths: 1,874
* Recovered: 13,105
SHORT ARTICLES/NEWS UPDATES
Short article/news updates in order of original publish date
Before 17 February 2020
Title: Fake news makes disease outbreaks worse, research shows
Published: Phys.org, 14 February 2020
From the article:
* The worry that fake news might be used to distort political processes or manipulate financial markets is well established. But less studied is the possibility that misinformation spread could harm human health, especially during the outbreak of an infectious disease.
Click here to read this article
17 February 2020
Title: Amid Covid-19 panic, thieves make off with hundreds of rolls of toilet paper in Hong Kong
Published: MarketWatch 17 February 2020
From the article:
* The territory has one of the highest incidences of confirmed cases of the deadly viral illnesses — 56 according to the World Health Organization — outside of the disease’s epicenter in mainland China. That has led to reports of panic buying of items such as masks, hand sanitizers and other goods, alongside viral photos of empty supermarket shelves.
Click here to read this article
Title: Antimalarial drug confirmed effective on COVID-19
Published: XinhuaNet, 17 February 2020
From the article:
* Chinese experts, based on the result of clinical trials, have confirmed that Chloroquine Phosphate, an antimalarial drug, has a certain curative effect on the novel coronavirus disease (COVID-19), a Chinese official said here Monday.
Click here to read this article
Title: Apple to miss revenue forecast as iPhone supply hit by coronavirus
Published: TechXplore, 17 February 2020
From the article:
* Apple announced Monday it would miss its March quarter revenue forecast and global iPhone supplies would fall because of the deadly coronavirus epidemic, triggering a fall in Asian stock markets.
Click here to read this article
Title: Covid-19 Resources
Published: Gov.sg, 17 February 2020
From the article:
* A collection of useful posters and videos on Covid-19 (Coronavirus Disease 2019).
Click here to read this article
Title: eSwatini (Swaziland): Suspected Coronavirus case tests negative
Published: APA News, 17 February 2020
From the article:
* An eSwatini woman suspected of having contracted Coronavirus (Covid-19) has tested negative of the dreaded disease, health officials announced on Monday.
Click here to read this article
Title: Misinformation about COVID-19 hurting many Vancouver Chinese businesses
Published: Citi News 1130, 17 February 2020
From the article:
* The operator of a Vancouver Chinese restaurant fears the business won’t last three more months due to misinformation being spread about the COVID-19 outbreak.
Click here to read this article
Title: Xi had early knowledge of coronavirus severity, speech shows
Published: News24, 17 February 2020
From the article:
* In the early days of the epidemic, which has been one of the biggest political challenges of Xi's tenure, the president seemed to play a muted role, partly fuelling criticism of the government's approach to the outbreak.
* But during a speech Xi delivered on February 3, which was published by state media on Saturday, he said he gave instructions on fighting the virus as early as January 7.
* In the address, Xi said he ordered the shutdowns at the epicentre: "On January 22, in light of the epidemic's rapid spread and the challenges of prevention and control, I made a clear request that Hubei province implement comprehensive and stringent controls over the outflow of people."
Click here to read this article
18 February 2020
Title: China approves first anti-viral drug against coronavirus Covid-19
Published: Pharmaceutical-technology.com, 18 February 2020
From the article:
* Anti-viral drug Favilavir has secured approval from the National Medical Products Administration of China to treat coronavirus Covid-19, according to media reports..
Click here to read this article
Title: Most coronavirus infections are mild, says Chinese study
Published: Medical Xpress, 18 February 2020
From the article:
* Most people infected by the new coronavirus in China have mild symptoms, with older patients and those with underlying conditions most at risk from the disease, according to a study by Chinese researchers.
Click here to read this article
Title: Wuhan director & family dies of Covid-19 virus after delays in treatment due to lack of hospital beds
Published: Mothership, 18 February 2020
From the article:
* A Chinese film director from Hubei province, 55-year-old Chang Kai, died from Covid-19.
* Within 12 days, not only did Covid-19 take Chang’s life, but it also killed his sister and parents.
Click here to read this article
Friday, February 14, 2020
Comprehensive List of Coronavirus-related Scholarly Articles (2019 & 2020), including MERS & SARS, as well as Covid-19 / 2019 Novel Coronavirus
Comprehensive List of Coronavirus-related Scholarly Articles (2019 & 2020), including MERS & SARS, as well as Covid-19 / 2019 Novel Coronavirus
[Compiled by E Retief]
In alphabetical order:
A
Adney, D.R. [et al.]. 2019. Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas. Viruses, 11(3). Doi: https://doi.org/10.3390/v11030212
Al-Abdely H.M. [et al.]. 2019. Middle East respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia. Emerging Infectious Diseases, 25(4):753-766. Available: https://wwwnc.cdc.gov/eid/article/25/4/18-1595_article
Alanazi, K.H. [et al.]. 2019. Scope and extent of healthcare-associated Middle East respiratory syndrome coronavirus transmission during two contemporaneous outbreaks in Riyadh, Saudi Arabia, 2017. Infection Control & Hospital Epidemiology, 40 (1):79-88. Available: https://www.ncbi.nlm.nih.gov/pubmed/30595141
Aldohyan, M. [et al.]. 2019. The perceived effectiveness of MERS-CoV educational programs and knowledge transfer among primary healthcare workers: a cross-sectional survey. BMC Infectious Diseases, 19. Available: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-3898-2
Alfaraj, S.H. [et al.]. 2019. Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia. Frontiers in Medecine, 13:126–130. Available: https://www.ncbi.nlm.nih.gov/pubmed/30872071
Alfaraj, S.H. [et al.]. 2019. Clinical predictors of mortality of Middle East Respiratory Syndrome (MERS) infection: a cohort study 2019. Travel Medicine and Infectious Disease, 29:48-50. Doi: https://doi.org/10.1016/j.tmaid.2019.03.004
Al-Tawfiq, J.A. & Gautret, P. 2019. Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review. Travel Medicine and Infectious Disease, 27, pp.27-32. Doi: https://doi.org/10.1016/j.tmaid.2018.12.003
Al-Tawfiq, J.A. & Auwaerter, P.G. Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature. Journal of ospital Infection, 101:20-29. Doi: https://doi.org/10.1016/j.jhin.2018.05.021
Arabi, Y.M. [et al.]. 2019. Macrolides in critically ill patients with Middle East Respiratory syndrome. The International Journal of Infectious Diseases, 81:184-190. Doi: https://doi.org/10.1016/j.ijid.2019.01.041
Azhar, E.I. [et al.]. 2019. The Middle East Respiratory Syndrome (MERS). Infectious Disease Clinics of North America, 33 (4):891-905. Available: https://www.ncbi.nlm.nih.gov/pubmed/27966107
B
Baharoon, S. & Memish, Z.A. 2019. MERS-CoV as an emerging respiratory illness: A review of prevention methods. Travel Medicine and Infectious Disease, 32. Available: https://doi.org/10.1016/j.tmaid.2019.101520
Benvenuto, D. [et al.]. January 2020. The 2019‐new coronavirus epidemic: Evidence for virus evolution. Journal of Medical Virology. Doi: https://doi.org/10.1002/jmv.25688
Biscayart, C. [et al.]. January 2020. The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? – Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI). Travel Medicine and Infectious Disease. Doi: https://doi.org/10.1016/j.tmaid.2020.101567
Bogoch, I.I. [et al.]. January 2020. Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel. Journal of Travel Medicine. Doi: https://doi.org/10.1093/jtm/taaa008
Bonilla-Aldana, D.K. [et al.]. January 2020. SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysis. Travel Medicine and Infectious Disease. Doi: https://doi.org/10.1016/j.tmaid.2020.101566
[In Press, Corrected Proof]
C
Centers for Disease Control and Prevention (CDC). February 2020. Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection. Available: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
Centers for Disease Control and Prevention (CDC). February 2020. Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for 2019 Novel Coronavirus (2019-nCoV). Available: https://www.cdc.gov/coronavirus/2019-ncov/downloads/guidance-home-care.pdf
Chan, J.F-W. [et al.]. February 2020. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 395(10223). Doi: https://doi.org/10.1016/S0140-6736(20)30154-9
Chang, D. [et al.]. February 2020. Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan China. JAMA. [Research Letter]. Available: https://jamanetwork.com/journals/jama/fullarticle/2761043
Chen, J. February 2020. Pathogenicity and Transmissibility of 2019-nCoV—A Quick Overview and Comparison with Other Emerging Viruses. Microbes and Infection. Available: https://www.sciencedirect.com/science/article/pii/S1286457920300265 [In Press, Journal Pre-proof]
Chen, N. [et al.]. February 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395(10223). Doi: https://doi.org/10.1016/S0140-6736(20)30211-7
Chen, Y., Liu, Q. & Guo, D. 2020. Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of Medical Virology. Doi: 10.1002/jmv.25681
Chen, Z-M. [et al.]. February 2020. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World Journal of Pediatrics. Available: https://link.springer.com/article/10.1007/s12519-020-00345-5
Cheng, V.C.C. [et al.]. 2020. Preparedness and proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China. The Journal of Hospital Infection. Doi: 10.1016/j.jhin.2020.01.010
China, National Health Commission of the People's Republic. January 2020. 2nd ed. New coronavirus pneumonia prevention and control program [in Mandarin]. Available: http://www.nhc.gov.cn/jkj/s3577/202001/c67cfe29ecf1470e8c7fc47d3b751e88.shtml
Corman, V.M. [et al.]. January 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance, 25(3). Available: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045
Coutard, B. [et al.]. February 2020. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Research. Doi: https://doi.org/10.1016/j.antiviral.2020.104742 [In Press, Journal Pre-proof]
Chu, D.K.W. [et al.]. January 2020. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clinical Chemistry. Doi: https://doi.org/10.1093/clinchem/hvaa029
Cui, J., Li, F. & Shi, Z.-L. Marc 2019. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, 17:181-192. Available: https://www.nature.com/articles/s41579-018-0118-9
D
Daszak, P., Olival, K.J. & Li, H. February 2020. A strategy to prevent future epidemics similar to the 2019-nCoV outbreak. Biosafety and Health. Doi: https://doi.org/10.1016/j.bsheal.2020.01.003
Del Rio, C. & Malani, P.N. February 2020. 2019 Novel coronavirus - important information for clinicians. JAMA. Available: https://jamanetwork.com/journals/jama/fullarticle/2760782
E
Esam, I. [et al.]. December 2019. The Middle East Respiratory Syndrome (MERS). Infection, Genetics and Evolution, 33(4):891-905. Available: https://www.researchgate.net/publication/337659485_The_Middle_East_Respiratory_Syndrome_MERS
European Centre for Disease Prevention and Control (ECDC). January 2020. Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) Middle East Respiratory Syndrome Coronavirus (MERS-CoV). ECDC Technical Report. Available: https://www.ecdc.europa.eu/en/publications-data/risk-assessment-guidelines-infectious-diseases-transmitted-aircraft-ragida-middle
F
Fan, Y. [et al.]. March 2019. Bat coronaviruses in China. Viruses, 11(3). Doi: https://doi.org/10.3390/v11030210
Farag, E.A.B. [et al.]. 2019. Survey on Implementation of One Health Approach for MERS-CoV Preparedness and Control in Gulf Cooperation Council and Middle East Countries. Emerging Infectious Diseases, 25(3). doi: 10.3201/eid2503.171702
Fung, T.S. & Liu, D.X. 2019. Human coronavirus: host-pathogen interaction. Annual Reviews Microbiology, 73, pp.529-557. Available: https://www.annualreviews.org/doi/10.1146/annurev-micro-020518-115759
G
Gardner, E.G. [et al.]. 2019. A case-crossover analysis of the impact of weather on primary cases of Middle East respiratory syndrome. BMC Infectious Diseases, 19(1):113. Available: https://www.ncbi.nlm.nih.gov/pubmed/30717685
Gralinski, L.E. & Menachery, V.D. January 2020. Return of the coronavirus: 2019-nCoV. Viruses, 12(2). Doi: https://doi.org/10.3390/v12020135
Gorbalenya, A.E. [et al.]. February 2020. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv. Doi: https://doi.org/10.1101/2020.02.07.937862
Guo, L. [et al.]. 2019. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score. Frontiers in Microbiology. Doi: https://doi.org/10.3389/fmicb.2019.02752
H
Hashem, A.M. [et al.]. 2019. Development and validation of different indirect ELISAs for MERS-CoV serological testing. Journal of Immunological Methods, 466:41-46. Doi: https://doi.org/10.1016/j.jim.2019.01.005
Heymann, D.L. February 2020. COVID-19: wat is next for public health? Lancet [article only available online at this stage]. Doi: https://doi.org/10.1016/S0140-6736(20)30374-3
Holshue, M.L. [et al.]. January 2020. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine. Available: https://www.nejm.org/doi/full/10.1056/NEJMoa2001191
Huang, C. [et al.]. January 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506. Doi: https://doi.org/10.1016/S0140-6736(20)30183-5
Hui, D.S. [et al.]. 2020. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases, 91:264-266. Doi: https://doi.org/10.1016/j.ijid.2020.01.009
Hui, D.S.C. & Zumla, A. 2019. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infectious Diseases Clinics of America, 33(4):869-889. Available: https://www.ncbi.nlm.nih.gov/pubmed/31668196
I
Imai, N. [et al.]. January 2020. Estimating the potential total number of novel Coronavirus cases in Wuhan City, China. Imperial College London. Available: http://www.bangkokhealth.com/v2/2019_nCoV_outbreak_report_Imperial_College_20200117.pdf
J
Ji, W. [et al.]. January 2020. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. Journal of Medical Virology. Available: https://www.ncbi.nlm.nih.gov/pubmed/31967321
Jiang, S., Du, L. & Shi, Z. January 2020. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerging Microbes & Infections, 9(1). Doi: https://doi.org/10.1080/22221751.2020.1723441
K
Kampf, G. [et al.]. 2020. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. The Journal of Hospital Infection. Doi: https://doi.org/10.1016/j.jhin.2020.01.022
Kandeil, A. [et al.]. 2019. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals. Emerging Microbes & Infections, 8:103-108. Doi: https://doi.org/10.1080/22221751.2018.1560235
Kanne, J.P. February 2020. Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist. Radiology. Doi: https://doi.org/10.1148/radiol.2020200241
Khan, S. [et al.]. 2020. Novel coronavirus is putting the whole world on alert. The Journal of Hospital Infection. Available: https://www.journalofhospitalinfection.com/article/S0195-6701(20)30043-8/fulltext
Kirchdoerfer, R.N. & Ward, A.B. 2019. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nature Communications. Available: https://www.nature.com/articles/s41467-019-10280-3
L
Lei, J. [et al.]. 2020. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. Available: https://pubs.rsna.org/doi/10.1148/radiol.2020200230
Li, H. [et al.]. 2020. A qualitative study of zoonotic risk among rural communities in Southern China. International Health, 12. Doi: 10.1093/inthealth/ihaa001
Li, H. [et al.]. 2019. Human-animal interactions and bat coronavirus spillover potential among rural residents in Southern China. Biosafety and Health, 1. Doi: 10.1016/j.bsheal.2019.10.004
Li, Q. [et al.]. January 2020. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England Journal of Medicine. Doi: 10.1056/NEJMoa2001316
[Chinese Translation: https://nejmqianyan.cn/article/YXQYoa2001316?sg=AbW1NGsHw3NxPd6F]
Liao, X, Wang, B. & Kang, Y. 2020. Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China. Intensive Care Medicine. Available: https://link.springer.com/article/10.1007%2Fs00134-020-05954-2
Liu, L. [et al.]. 2019. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight, 4(4). Available: https://www.ncbi.nlm.nih.gov/pubmed/30830861
Liu, Y-C. [et al.]. February 2020. A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan. [Correspondence]. The New England Journal of Medicine. Available: https://www.nejm.org/doi/full/10.1056/NEJMc2001573
Lu, H., Stratton, C.W. & Tang, Y.W. January 2020. Outbreak of pneumonia of unknown etiology in wuhan China: the mystery and the miracle. Journal of Medical Virology. Doi: https://doi.org/10.1002/jmv.25678
Luo, G.G. & Gao, S.J. January 2020. Global health concern stirred by emerging viral infections. Journal of Medical Virology. Doi: 10.1002/jmv.25683
Luk, H.K.H. [et al.]. 2019. Molecular epidemiology, evolution and phylogeny of SARS coronavirus Infection, Genetics and Evolution, 71:21-30. Doi: https://doi.org/10.1016/j.meegid.2019.03.001
M
Metlay, J.P. [et al.]. 2019. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 200(7):e45-e67. Doi: https://doi.org/10.1164/rccm.201908-1581ST
Momattin, H., Al-Ali, A.Y. & Al-Tawfiq, J.A. 2019. A systematic review of therapeutic agents for the treatment of the Middle East respiratory syndrome coronavirus (MERS-CoV). Travel Medicine and Infectious Disease. Doi: https://doi.org/10.1016/j.tmaid.2019.06.012
Munster, V.J. [et al.]. January 2020. A novel coronavirus emerging in China — key questions for impact assessment. The New England Journal of Medicine. Doi: 10.1056/NEJMp2000929
[Chinese Translation: https://nejmqianyan.cn/article/YXQYp2000929?sg=AbW1NGsHw3NxPd6F]
P
Pan, Y. & Guan, H. 2020. Imaging changes in patients with 2019-nCov. European Radiology. Available: https://link.springer.com/article/10.1007%2Fs00330-020-06713-z
Paraskevis, D. [et al.]. April 2020. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infection, Genetics and Evolution, 79. Doi: https://doi.org/10.1016/j.meegid.2020.104212
Park, S.Y. [et al.]. 2019. Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers. Journal of Hospital Infection, 101(1):42-46. Doi: https://doi.org/10.1016/j.jhin.2018.09.005
Parr, J. January 2020. Pneumonia in China: lack of information raises concerns among Hong Kong health workers. BMJ, 368. [News]. Doi: https://doi.org/10.1136/bmj.m56
Paules, C.I., Marston, H.D. & Fauci, A.S. January 2020. Coronavirus infections-more than just the common cold. JAMA. Doi: 10.1001/jama.2020.0757
Phan, L.T. [et al.]. January 2020. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. The New England Journal of Medicine. Available: https://www.nejm.org/doi/full/10.1056/NEJMc2001272
Phan, T. April 2020. Novel coronavirus: From discovery to clinical diagnostics. Infection, Genetics and Evolution, 79. Doi: https://doi.org/10.1016/j.meegid.2020.104211
Perlman, S. January 2020. Another decade, another coronavirus. The New England Journal of Medicine. Available: https://www.nejm.org/doi/pdf/10.1056/NEJMe2001126
Q
Qiao, J. February 2020. What are the risks of COVID-19 infection in pregnant women? Lancet [article only available online at this stage]. Doi: https://doi.org/10.1016/S0140-6736(20)30365-2
R
Ramadan, N. & Shaib, H. 2019. Middle East respiratory syndrome coronavirus (MERS-CoV): A review. Germs, 9, pp.35-42. Available: https://www.ncbi.nlm.nih.gov/pubmed/31119115
Rodriguez-Morales, A.J. 2020. History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus Epidemic. Le Infezioni in Medicina, 1:3-5. Available: https://www.infezmed.it/media/journal/Vol_28_1_2020_1.pdf
Russell, C.D., Millar, J.E. & Baillie, J.K. February 2020. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet, 395(10223):473-475. Doi: https://doi.org/10.1016/S0140-6736(20)30317-2
S
Seah, I., Su, X. & Lingam, G. February 2020. Revisiting the dangers of the coronavirus in the ophthalmology practice. Eye. Available: https://www.nature.com/articles/s41433-020-0790-7
Sheahan, T.P. [et al.]. January 2020. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta
against MERS-CoV. Nature Communications, 11. Available: https://www.nature.com/articles/s41467-019-13940-6
Schindewolf, C. & Menachery, V.D. 2019. Middle East respiratory syndrome vaccine candidates: cautious optimism. Viruses, 11(1). Available: https://www.ncbi.nlm.nih.gov/pubmed/30658390
Schoeman, D & Fielding, B.C. May 2019. Coronavirus envelope protein: current knowledge. Virology Journal. Available: https://virologyj.biomedcentral.com/articles/10.1186/s12985-019-1182-0
Sheahan, T.P. [et al.]. January 2020. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature Communications, 11(1). doi:10.1038/s41467-019-13940-6
Stecher, G., Tamura, K. & Kumar, S. January 2020. Molecular Evolutionary Genetics Analysis (MEGA) for macOS. Molecular Biology and Evolution. Doi: https://doi.org/10.1093/molbev/msz312
Song, F. [et al.]. February 2020. Emerging coronavirus 2019-nCoV pneumonia. Radiology. Doi: https://doi.org/10.1148/radiol.2020200274
Song, Y. [et al.]. Prospect and application of Internet of Things technology for prevention of SARIs. Clinical eHealth, 3:1-4. Doi: https://doi.org/10.1016/j.ceh.2020.02.001
Song, Z. [et al.]. 2019. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 11(1). Doi:10.3390/v11010059
T
Tan, W. [et al.]. 2020. A novel coronavirus genome identified in a cluster of pneumonia cases — Wuhan, China 2019−2020. [A CCDC Weekly publication]. Available: http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c
W
Wan, Y. [et al.]. 2002. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. Journal of Virology. Doi: http://dx.doi.org/10.1128/JVI.00127-20
Wang, D. [et al.]. February 2020. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan. JAMA. Doi: 10.1001/jama.2020.1585
Wang, L.F. & Anderson, D.E. 2019. Viruses in bats and potential spillover to animals and humans. Current Opinion in Virology, 34. Doi: https://doi.org/10.1016/j.coviro.2019.12.007
Wang, M. [et al.]. February 2020. A precision medicine approach to managing Wuhan Coronavirus pneumonia. Precision Clinical Medicine. Doi: https://doi.org/10.1093/pcmedi/pbaa002
Wang, M. [et al.]. 2020. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research. Available: https://doi.org/10.1038/s41422-020-0282-0
Wei, J. [et al.]. January 2020. Homologous recombination witin the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. Journal of Medical Virology. Doi: https://doi.org/10.1002/jmv.25682
Wei, X., Li, X. & Cui, J. January 2020. Evolutionary Perspectives on Novel Coronaviruses Identified in Pneumonia Cases in China. National Science Review. Doi: https://doi.org/10.1093/nsr/nwaa009
Widagdo, W. [et al.]. March 2019. Host Determinants of MERS-VoV Transmission and Pathogenesis. Viruses, 11(3). Doi: https://doi.org/10.3390/v11030280
Widjaja, I. [et al.]. 2019. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Emerging Microbes and Infections, 8(1):516-530. Doi: https://doi.org/10.1080/22221751.2019.1597644
Wong, A.C.P. [et al.]. September 2019. Global Epidemiology of Bat Coronaviruses. Viruses, 11(2). Doi: 10.3390/v11020174
World Health Organisation (WHO). January 2020. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Available: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf
World Health Organisation (WHO). November 2019. Middle East respiratory syndrome coronavirus (MERS-CoV) Available at: https://www.who.int/emergencies/mers-cov/en/
Wu, P. [et al.]. January 2020. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Eurosurveillance, 25(3). Available: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000044
Wuhan Municipal Health Commission. 31 December 2019. Briefing on clustering pneumonia of unknown etiology in Wuhan City [in Mandarin]. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989
Wuhan Municipal Health Commission. 3 January 2020. Briefing on the pneumonia epidemic situation [in Mandarin].
[Compiled by E Retief]
In alphabetical order:
A
Adney, D.R. [et al.]. 2019. Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas. Viruses, 11(3). Doi: https://doi.org/10.3390/v11030212
Al-Abdely H.M. [et al.]. 2019. Middle East respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia. Emerging Infectious Diseases, 25(4):753-766. Available: https://wwwnc.cdc.gov/eid/article/25/4/18-1595_article
Alanazi, K.H. [et al.]. 2019. Scope and extent of healthcare-associated Middle East respiratory syndrome coronavirus transmission during two contemporaneous outbreaks in Riyadh, Saudi Arabia, 2017. Infection Control & Hospital Epidemiology, 40 (1):79-88. Available: https://www.ncbi.nlm.nih.gov/pubmed/30595141
Aldohyan, M. [et al.]. 2019. The perceived effectiveness of MERS-CoV educational programs and knowledge transfer among primary healthcare workers: a cross-sectional survey. BMC Infectious Diseases, 19. Available: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-3898-2
Alfaraj, S.H. [et al.]. 2019. Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia. Frontiers in Medecine, 13:126–130. Available: https://www.ncbi.nlm.nih.gov/pubmed/30872071
Alfaraj, S.H. [et al.]. 2019. Clinical predictors of mortality of Middle East Respiratory Syndrome (MERS) infection: a cohort study 2019. Travel Medicine and Infectious Disease, 29:48-50. Doi: https://doi.org/10.1016/j.tmaid.2019.03.004
Al-Tawfiq, J.A. & Gautret, P. 2019. Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review. Travel Medicine and Infectious Disease, 27, pp.27-32. Doi: https://doi.org/10.1016/j.tmaid.2018.12.003
Al-Tawfiq, J.A. & Auwaerter, P.G. Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature. Journal of ospital Infection, 101:20-29. Doi: https://doi.org/10.1016/j.jhin.2018.05.021
Arabi, Y.M. [et al.]. 2019. Macrolides in critically ill patients with Middle East Respiratory syndrome. The International Journal of Infectious Diseases, 81:184-190. Doi: https://doi.org/10.1016/j.ijid.2019.01.041
Azhar, E.I. [et al.]. 2019. The Middle East Respiratory Syndrome (MERS). Infectious Disease Clinics of North America, 33 (4):891-905. Available: https://www.ncbi.nlm.nih.gov/pubmed/27966107
B
Baharoon, S. & Memish, Z.A. 2019. MERS-CoV as an emerging respiratory illness: A review of prevention methods. Travel Medicine and Infectious Disease, 32. Available: https://doi.org/10.1016/j.tmaid.2019.101520
Benvenuto, D. [et al.]. January 2020. The 2019‐new coronavirus epidemic: Evidence for virus evolution. Journal of Medical Virology. Doi: https://doi.org/10.1002/jmv.25688
Biscayart, C. [et al.]. January 2020. The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? – Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI). Travel Medicine and Infectious Disease. Doi: https://doi.org/10.1016/j.tmaid.2020.101567
Bogoch, I.I. [et al.]. January 2020. Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel. Journal of Travel Medicine. Doi: https://doi.org/10.1093/jtm/taaa008
Bonilla-Aldana, D.K. [et al.]. January 2020. SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysis. Travel Medicine and Infectious Disease. Doi: https://doi.org/10.1016/j.tmaid.2020.101566
[In Press, Corrected Proof]
C
Centers for Disease Control and Prevention (CDC). February 2020. Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection. Available: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
Centers for Disease Control and Prevention (CDC). February 2020. Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for 2019 Novel Coronavirus (2019-nCoV). Available: https://www.cdc.gov/coronavirus/2019-ncov/downloads/guidance-home-care.pdf
Chan, J.F-W. [et al.]. February 2020. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 395(10223). Doi: https://doi.org/10.1016/S0140-6736(20)30154-9
Chang, D. [et al.]. February 2020. Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan China. JAMA. [Research Letter]. Available: https://jamanetwork.com/journals/jama/fullarticle/2761043
Chen, J. February 2020. Pathogenicity and Transmissibility of 2019-nCoV—A Quick Overview and Comparison with Other Emerging Viruses. Microbes and Infection. Available: https://www.sciencedirect.com/science/article/pii/S1286457920300265 [In Press, Journal Pre-proof]
Chen, N. [et al.]. February 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395(10223). Doi: https://doi.org/10.1016/S0140-6736(20)30211-7
Chen, Y., Liu, Q. & Guo, D. 2020. Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of Medical Virology. Doi: 10.1002/jmv.25681
Chen, Z-M. [et al.]. February 2020. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World Journal of Pediatrics. Available: https://link.springer.com/article/10.1007/s12519-020-00345-5
Cheng, V.C.C. [et al.]. 2020. Preparedness and proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China. The Journal of Hospital Infection. Doi: 10.1016/j.jhin.2020.01.010
China, National Health Commission of the People's Republic. January 2020. 2nd ed. New coronavirus pneumonia prevention and control program [in Mandarin]. Available: http://www.nhc.gov.cn/jkj/s3577/202001/c67cfe29ecf1470e8c7fc47d3b751e88.shtml
Corman, V.M. [et al.]. January 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance, 25(3). Available: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045
Coutard, B. [et al.]. February 2020. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Research. Doi: https://doi.org/10.1016/j.antiviral.2020.104742 [In Press, Journal Pre-proof]
Chu, D.K.W. [et al.]. January 2020. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clinical Chemistry. Doi: https://doi.org/10.1093/clinchem/hvaa029
Cui, J., Li, F. & Shi, Z.-L. Marc 2019. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, 17:181-192. Available: https://www.nature.com/articles/s41579-018-0118-9
D
Daszak, P., Olival, K.J. & Li, H. February 2020. A strategy to prevent future epidemics similar to the 2019-nCoV outbreak. Biosafety and Health. Doi: https://doi.org/10.1016/j.bsheal.2020.01.003
Del Rio, C. & Malani, P.N. February 2020. 2019 Novel coronavirus - important information for clinicians. JAMA. Available: https://jamanetwork.com/journals/jama/fullarticle/2760782
E
Esam, I. [et al.]. December 2019. The Middle East Respiratory Syndrome (MERS). Infection, Genetics and Evolution, 33(4):891-905. Available: https://www.researchgate.net/publication/337659485_The_Middle_East_Respiratory_Syndrome_MERS
European Centre for Disease Prevention and Control (ECDC). January 2020. Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) Middle East Respiratory Syndrome Coronavirus (MERS-CoV). ECDC Technical Report. Available: https://www.ecdc.europa.eu/en/publications-data/risk-assessment-guidelines-infectious-diseases-transmitted-aircraft-ragida-middle
F
Fan, Y. [et al.]. March 2019. Bat coronaviruses in China. Viruses, 11(3). Doi: https://doi.org/10.3390/v11030210
Farag, E.A.B. [et al.]. 2019. Survey on Implementation of One Health Approach for MERS-CoV Preparedness and Control in Gulf Cooperation Council and Middle East Countries. Emerging Infectious Diseases, 25(3). doi: 10.3201/eid2503.171702
Fung, T.S. & Liu, D.X. 2019. Human coronavirus: host-pathogen interaction. Annual Reviews Microbiology, 73, pp.529-557. Available: https://www.annualreviews.org/doi/10.1146/annurev-micro-020518-115759
G
Gardner, E.G. [et al.]. 2019. A case-crossover analysis of the impact of weather on primary cases of Middle East respiratory syndrome. BMC Infectious Diseases, 19(1):113. Available: https://www.ncbi.nlm.nih.gov/pubmed/30717685
Gralinski, L.E. & Menachery, V.D. January 2020. Return of the coronavirus: 2019-nCoV. Viruses, 12(2). Doi: https://doi.org/10.3390/v12020135
Gorbalenya, A.E. [et al.]. February 2020. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv. Doi: https://doi.org/10.1101/2020.02.07.937862
Guo, L. [et al.]. 2019. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score. Frontiers in Microbiology. Doi: https://doi.org/10.3389/fmicb.2019.02752
H
Hashem, A.M. [et al.]. 2019. Development and validation of different indirect ELISAs for MERS-CoV serological testing. Journal of Immunological Methods, 466:41-46. Doi: https://doi.org/10.1016/j.jim.2019.01.005
Heymann, D.L. February 2020. COVID-19: wat is next for public health? Lancet [article only available online at this stage]. Doi: https://doi.org/10.1016/S0140-6736(20)30374-3
Holshue, M.L. [et al.]. January 2020. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine. Available: https://www.nejm.org/doi/full/10.1056/NEJMoa2001191
Huang, C. [et al.]. January 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506. Doi: https://doi.org/10.1016/S0140-6736(20)30183-5
Hui, D.S. [et al.]. 2020. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases, 91:264-266. Doi: https://doi.org/10.1016/j.ijid.2020.01.009
Hui, D.S.C. & Zumla, A. 2019. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infectious Diseases Clinics of America, 33(4):869-889. Available: https://www.ncbi.nlm.nih.gov/pubmed/31668196
I
Imai, N. [et al.]. January 2020. Estimating the potential total number of novel Coronavirus cases in Wuhan City, China. Imperial College London. Available: http://www.bangkokhealth.com/v2/2019_nCoV_outbreak_report_Imperial_College_20200117.pdf
J
Ji, W. [et al.]. January 2020. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. Journal of Medical Virology. Available: https://www.ncbi.nlm.nih.gov/pubmed/31967321
Jiang, S., Du, L. & Shi, Z. January 2020. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerging Microbes & Infections, 9(1). Doi: https://doi.org/10.1080/22221751.2020.1723441
K
Kampf, G. [et al.]. 2020. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. The Journal of Hospital Infection. Doi: https://doi.org/10.1016/j.jhin.2020.01.022
Kandeil, A. [et al.]. 2019. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals. Emerging Microbes & Infections, 8:103-108. Doi: https://doi.org/10.1080/22221751.2018.1560235
Kanne, J.P. February 2020. Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist. Radiology. Doi: https://doi.org/10.1148/radiol.2020200241
Khan, S. [et al.]. 2020. Novel coronavirus is putting the whole world on alert. The Journal of Hospital Infection. Available: https://www.journalofhospitalinfection.com/article/S0195-6701(20)30043-8/fulltext
Kirchdoerfer, R.N. & Ward, A.B. 2019. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nature Communications. Available: https://www.nature.com/articles/s41467-019-10280-3
L
Lei, J. [et al.]. 2020. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. Available: https://pubs.rsna.org/doi/10.1148/radiol.2020200230
Li, H. [et al.]. 2020. A qualitative study of zoonotic risk among rural communities in Southern China. International Health, 12. Doi: 10.1093/inthealth/ihaa001
Li, H. [et al.]. 2019. Human-animal interactions and bat coronavirus spillover potential among rural residents in Southern China. Biosafety and Health, 1. Doi: 10.1016/j.bsheal.2019.10.004
Li, Q. [et al.]. January 2020. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England Journal of Medicine. Doi: 10.1056/NEJMoa2001316
[Chinese Translation: https://nejmqianyan.cn/article/YXQYoa2001316?sg=AbW1NGsHw3NxPd6F]
Liao, X, Wang, B. & Kang, Y. 2020. Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China. Intensive Care Medicine. Available: https://link.springer.com/article/10.1007%2Fs00134-020-05954-2
Liu, L. [et al.]. 2019. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight, 4(4). Available: https://www.ncbi.nlm.nih.gov/pubmed/30830861
Liu, Y-C. [et al.]. February 2020. A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan. [Correspondence]. The New England Journal of Medicine. Available: https://www.nejm.org/doi/full/10.1056/NEJMc2001573
Lu, H., Stratton, C.W. & Tang, Y.W. January 2020. Outbreak of pneumonia of unknown etiology in wuhan China: the mystery and the miracle. Journal of Medical Virology. Doi: https://doi.org/10.1002/jmv.25678
Luo, G.G. & Gao, S.J. January 2020. Global health concern stirred by emerging viral infections. Journal of Medical Virology. Doi: 10.1002/jmv.25683
Luk, H.K.H. [et al.]. 2019. Molecular epidemiology, evolution and phylogeny of SARS coronavirus Infection, Genetics and Evolution, 71:21-30. Doi: https://doi.org/10.1016/j.meegid.2019.03.001
M
Metlay, J.P. [et al.]. 2019. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 200(7):e45-e67. Doi: https://doi.org/10.1164/rccm.201908-1581ST
Momattin, H., Al-Ali, A.Y. & Al-Tawfiq, J.A. 2019. A systematic review of therapeutic agents for the treatment of the Middle East respiratory syndrome coronavirus (MERS-CoV). Travel Medicine and Infectious Disease. Doi: https://doi.org/10.1016/j.tmaid.2019.06.012
Munster, V.J. [et al.]. January 2020. A novel coronavirus emerging in China — key questions for impact assessment. The New England Journal of Medicine. Doi: 10.1056/NEJMp2000929
[Chinese Translation: https://nejmqianyan.cn/article/YXQYp2000929?sg=AbW1NGsHw3NxPd6F]
P
Pan, Y. & Guan, H. 2020. Imaging changes in patients with 2019-nCov. European Radiology. Available: https://link.springer.com/article/10.1007%2Fs00330-020-06713-z
Paraskevis, D. [et al.]. April 2020. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infection, Genetics and Evolution, 79. Doi: https://doi.org/10.1016/j.meegid.2020.104212
Park, S.Y. [et al.]. 2019. Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers. Journal of Hospital Infection, 101(1):42-46. Doi: https://doi.org/10.1016/j.jhin.2018.09.005
Parr, J. January 2020. Pneumonia in China: lack of information raises concerns among Hong Kong health workers. BMJ, 368. [News]. Doi: https://doi.org/10.1136/bmj.m56
Paules, C.I., Marston, H.D. & Fauci, A.S. January 2020. Coronavirus infections-more than just the common cold. JAMA. Doi: 10.1001/jama.2020.0757
Phan, L.T. [et al.]. January 2020. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. The New England Journal of Medicine. Available: https://www.nejm.org/doi/full/10.1056/NEJMc2001272
Phan, T. April 2020. Novel coronavirus: From discovery to clinical diagnostics. Infection, Genetics and Evolution, 79. Doi: https://doi.org/10.1016/j.meegid.2020.104211
Perlman, S. January 2020. Another decade, another coronavirus. The New England Journal of Medicine. Available: https://www.nejm.org/doi/pdf/10.1056/NEJMe2001126
Q
Qiao, J. February 2020. What are the risks of COVID-19 infection in pregnant women? Lancet [article only available online at this stage]. Doi: https://doi.org/10.1016/S0140-6736(20)30365-2
R
Ramadan, N. & Shaib, H. 2019. Middle East respiratory syndrome coronavirus (MERS-CoV): A review. Germs, 9, pp.35-42. Available: https://www.ncbi.nlm.nih.gov/pubmed/31119115
Rodriguez-Morales, A.J. 2020. History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus Epidemic. Le Infezioni in Medicina, 1:3-5. Available: https://www.infezmed.it/media/journal/Vol_28_1_2020_1.pdf
Russell, C.D., Millar, J.E. & Baillie, J.K. February 2020. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet, 395(10223):473-475. Doi: https://doi.org/10.1016/S0140-6736(20)30317-2
S
Seah, I., Su, X. & Lingam, G. February 2020. Revisiting the dangers of the coronavirus in the ophthalmology practice. Eye. Available: https://www.nature.com/articles/s41433-020-0790-7
Sheahan, T.P. [et al.]. January 2020. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta
against MERS-CoV. Nature Communications, 11. Available: https://www.nature.com/articles/s41467-019-13940-6
Schindewolf, C. & Menachery, V.D. 2019. Middle East respiratory syndrome vaccine candidates: cautious optimism. Viruses, 11(1). Available: https://www.ncbi.nlm.nih.gov/pubmed/30658390
Schoeman, D & Fielding, B.C. May 2019. Coronavirus envelope protein: current knowledge. Virology Journal. Available: https://virologyj.biomedcentral.com/articles/10.1186/s12985-019-1182-0
Sheahan, T.P. [et al.]. January 2020. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature Communications, 11(1). doi:10.1038/s41467-019-13940-6
Stecher, G., Tamura, K. & Kumar, S. January 2020. Molecular Evolutionary Genetics Analysis (MEGA) for macOS. Molecular Biology and Evolution. Doi: https://doi.org/10.1093/molbev/msz312
Song, F. [et al.]. February 2020. Emerging coronavirus 2019-nCoV pneumonia. Radiology. Doi: https://doi.org/10.1148/radiol.2020200274
Song, Y. [et al.]. Prospect and application of Internet of Things technology for prevention of SARIs. Clinical eHealth, 3:1-4. Doi: https://doi.org/10.1016/j.ceh.2020.02.001
Song, Z. [et al.]. 2019. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 11(1). Doi:10.3390/v11010059
T
Tan, W. [et al.]. 2020. A novel coronavirus genome identified in a cluster of pneumonia cases — Wuhan, China 2019−2020. [A CCDC Weekly publication]. Available: http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c
W
Wan, Y. [et al.]. 2002. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. Journal of Virology. Doi: http://dx.doi.org/10.1128/JVI.00127-20
Wang, D. [et al.]. February 2020. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan. JAMA. Doi: 10.1001/jama.2020.1585
Wang, L.F. & Anderson, D.E. 2019. Viruses in bats and potential spillover to animals and humans. Current Opinion in Virology, 34. Doi: https://doi.org/10.1016/j.coviro.2019.12.007
Wang, M. [et al.]. February 2020. A precision medicine approach to managing Wuhan Coronavirus pneumonia. Precision Clinical Medicine. Doi: https://doi.org/10.1093/pcmedi/pbaa002
Wang, M. [et al.]. 2020. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research. Available: https://doi.org/10.1038/s41422-020-0282-0
Wei, J. [et al.]. January 2020. Homologous recombination witin the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. Journal of Medical Virology. Doi: https://doi.org/10.1002/jmv.25682
Wei, X., Li, X. & Cui, J. January 2020. Evolutionary Perspectives on Novel Coronaviruses Identified in Pneumonia Cases in China. National Science Review. Doi: https://doi.org/10.1093/nsr/nwaa009
Widagdo, W. [et al.]. March 2019. Host Determinants of MERS-VoV Transmission and Pathogenesis. Viruses, 11(3). Doi: https://doi.org/10.3390/v11030280
Widjaja, I. [et al.]. 2019. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Emerging Microbes and Infections, 8(1):516-530. Doi: https://doi.org/10.1080/22221751.2019.1597644
Wong, A.C.P. [et al.]. September 2019. Global Epidemiology of Bat Coronaviruses. Viruses, 11(2). Doi: 10.3390/v11020174
World Health Organisation (WHO). January 2020. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Available: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf
World Health Organisation (WHO). November 2019. Middle East respiratory syndrome coronavirus (MERS-CoV) Available at: https://www.who.int/emergencies/mers-cov/en/
Wu, P. [et al.]. January 2020. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Eurosurveillance, 25(3). Available: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000044
Wuhan Municipal Health Commission. 31 December 2019. Briefing on clustering pneumonia of unknown etiology in Wuhan City [in Mandarin]. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989
Wuhan Municipal Health Commission. 3 January 2020. Briefing on the pneumonia epidemic situation [in Mandarin].
http://wjw.wuhan.gov.cn/front/web/showDetail/2020010309017
X
Xu, X. [et al.]. January 2020. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences. Available: https://link.springer.com/article/10.1007%2Fs11427-020-1637-5
Y
Yang, Y. [et al.]. February 2020. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv. Doi: https://doi.org/10.1101/2020.02.10.20021675
Z
Zhang, H. [et al.]. January 2020. The digestive system is a potential route of 2019 nCoV infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. doi:10.1101/2020.01.30.927806
Zhang, N. [et al.]. January 2020. Recent advances in the detection of respiratory virus infection in humans. Journal of Medical Virology. Doi: 10.1002/jmv.25674
Zhao, S. [et al.]. January 2020. The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report. Travel Medicine and Infectious Disease. Doi: https://doi.org/10.1016/j.tmaid.2020.101568
Zhou, P. [et al.]. 2020. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. Doi: 10.1101/2020.01.22.914952
Zhu, N. [et. al.]. January 2020. A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine. Doi:10.1056/NEJMoa2001017
X
Xu, X. [et al.]. January 2020. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences. Available: https://link.springer.com/article/10.1007%2Fs11427-020-1637-5
Y
Yang, Y. [et al.]. February 2020. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv. Doi: https://doi.org/10.1101/2020.02.10.20021675
Z
Zhang, H. [et al.]. January 2020. The digestive system is a potential route of 2019 nCoV infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. doi:10.1101/2020.01.30.927806
Zhang, N. [et al.]. January 2020. Recent advances in the detection of respiratory virus infection in humans. Journal of Medical Virology. Doi: 10.1002/jmv.25674
Zhao, S. [et al.]. January 2020. The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report. Travel Medicine and Infectious Disease. Doi: https://doi.org/10.1016/j.tmaid.2020.101568
Zhou, P. [et al.]. 2020. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. Doi: 10.1101/2020.01.22.914952
Zhu, N. [et. al.]. January 2020. A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine. Doi:10.1056/NEJMoa2001017
Subscribe to:
Posts (Atom)